Institutional investors hold a majority ownership of CELG through the 81.79% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended March 2016, these large investors purchased a net $12.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JOHN W. BRISTOL & CO., INC. (NEW... Bought 529.7 Thousand shares of Celgene